Ductus Arteriosus Clinical Trial
Official title:
The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Labour at Term
NCT number | NCT03073460 |
Other study ID # | 16-037 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | June 2, 2016 |
Est. completion date | March 28, 2020 |
Verified date | April 2020 |
Source | St. Michael's Hospital, Toronto |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The exact mechanism stimulating the parturition in humans is still relatively unknown. Prostaglandins, by mediating cervical ripening and early stimulation of myometrial contractions, are likely to play a major role in the parturition process. Much of the unique fetal circulation is facilitated by the ductus arteriosus. Patency of the ductus arteriosus in utero is primarily maintained via prostaglandins which are highly expressed by smooth muscle cells located in the media of the ductus arteriosus. The aim of the study is to prospectively observe fetal ultrasound changes related to the ductus arteriosus. The primary objective is to prospectively assess, whether any changes in the fetal ductus arteriosus parameters exist at 40 weeks' gestation. The secondary objective is to investigate whether there is an association between the ductus arteriosus parameters and the time to delivery interval at 40 weeks' gestation.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | March 28, 2020 |
Est. primary completion date | March 28, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion criteria: - Low risk singleton pregnancy at 40 weeks gestation. Exclusion criteria: - Smoking - Underlying cardiac or respiratory illness - Fetal growth restriction - Medicated gestational hypertension or evolving preeclampsia - Gestational diabetes controlled with insulin or oral medications - Use of steroids for lung maturation in the current pregnancy - Known major congenital anomalies. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
St. Michael's Hospital, Toronto |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fetal ductus arteriosus changes | To prospectively assess whether any changes in blood flow in the fetal ductus arteriosus exist at 40 weeks' gestation. | 40 weeks gestation | |
Secondary | Time to delivery | To investigate whether there is an association between the ductus arteriosus blood flow and the time to delivery interval at 40 weeks' gestation. | From 40 weeks gestation to delivery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03073512 -
The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Preterm Birth
|
N/A | |
Completed |
NCT05922488 -
Effect of Umbilical Cord Milking Versus Clamping in Preterms on Cerebral Oxygenation and Ductus Arteriosus Closure
|
N/A |